Indole sPLA2 inhibitors
US6451839B1 · kind B1 · utility
2Cited by
7References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2001 |
| Grant date | Sep 17, 2002 |
| Priority date | — |
| Expiry date | Jan 30, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of novel indole is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of inflammatory diseases such as septic shock.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.